Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? Comments.]
Probenecid Application Prevents Clinical Symptoms and Inflammation in Experimental Autoimmune Encephalomyelitis.
Evaluation of the circulating CD34(+), CD309(+), and endothelial progenitor cells in patients with first attack of optic neuritis.
Mechanistic Perspectives of Maslinic Acid in Targeting Inflammation.
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data.
Strength: A Relevant Link to Functional Performance in the Neurodegenerative Disease of Adrenomyeloneuropathy.
Selective estrogen-receptor modulators suppress microglial activation and neuronal cell death via an estrogen receptor-dependent pathway.
Randomized trial of erhuangfang for relapsing multiple sclerosis.
Why some of us do not like the expression "no evidence of disease activity" (NEDA) in multiple sclerosis.
New evidence for teriflunomide in multiple sclerosis.
Molecular mechanisms linking neuroinflammation and neurodegeneration in MS.
Control of microglial neurotoxicity by the fractalkine receptor.
Age-dependent increase of blood-brain barrier permeability and neuron-binding autoantibodies in S100B knockout mice.
[Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? No.]
MHC and non-MHC gene regulation of disease susceptibility and disease course in experimental inflammatory peripheral neuropathy.
The Elderly Person With Multiple Sclerosis: Clinical Implications for the Increasing Lifespan.
Preclinical assessment of β-d-mannuronic acid (M2000) as a non-steroidal anti-inflammatory drug.
LOTUS, a possible endogenous inhibitor of axonal degeneration, as a new biomarker for multiple sclerosis.
MAIT cells in autoimmunity, immune mediated diseases and airways disease.
Evaluation of the impact of neutralizing antibodies on IFNβ response.
Decoding diffusivity in multiple sclerosis: analysis of optic radiation lesional and non-lesional white matter.
Can neurotrophic cytokines help to regenerate the mammalian central nervous system?
Neuromyelitis optica spectrum disorder in a patient with Kikuchi-Fujimoto disease.
Reciprocal communication between the nervous and immune systems: crosstalk, back-talk and motivational speeches.
Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis.
Pages
« first
‹ previous
…
693
694
695
696
697
698
699
700
701
…
next ›
last »